- Financial Times•3 hours ago
More than 20 of the world's leading drug companies have pledged to work together to treat cancer and other non-communicable diseases in poor and developing countries. Cancer and non-transmitted diseases ...
- Investor's Business Daily•10 hours ago
Regeneron and Sanofi argue Amgen's patents covering LDL-buster Repatha are too broad.
- GlobeNewswire•14 hours ago
Suliqua TM Approved in the European Union for the Treatment of Adults with Type 2 Diabetes Paris, France - January 18th , 2017 - Sanofi announced today that the European Commission has granted marketing ...
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||75.85 - 76.99|
|52 Week Range||62.50 - 79.07|
|PE Ratio (TTM)||23.36|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|